T1	Age 25 28	Age
E1	Age:T1 Eq-Comparison:E2
T2	Eq-Comparison 30 49	older than 18 years
E2	Eq-Comparison:T2 Operator:T83 Value:T84 Temporal-Unit:T85
T3	Observation 60 64	ECOG
E3	Observation:T3 Name:T86 Eq-Comparison:E4
T4	Eq-Comparison 85 88	0-2
E4	Eq-Comparison:T4 Value:T87 Operator:T88
T5	Condition 114 119	HNSCC
E5	Condition:T5 Name:T90
T6	Condition 125 128	HPV
E6	Condition:T6 Name:T91 Polarity:T94
T7	Or 145 147	or
E7	Or:T7 Arg:E6 Arg2:E8
T8	Condition 148 151	HPV
E8	Condition:T8 Name:T92 Polarity:T93
T9	Eq-Comparison 173 182	Stage III
E9	Eq-Comparison:T9 Unit:T95 Value:T96
T11	Or 188 190	or
E11	Or:T11 Arg:E10 Arg2:E12
T12	Modifier 191 194	IVB
E12	Modifier:T12 Modifies:T97
T13	Condition 195 200	HNSCC
E13	Condition:T13 Name:T97 Stage:E9
T14	Modifier 264 276	irresectable
E14	Modifier:T14 Modifies:T99
T15	Or 277 279	or
E15	Or:T15 Arg:E14 Arg2:E16
T16	Modifier 288 298	inoperable
E16	Modifier:T16 Modifies:T99
T17	Or 299 301	or
E17	Or:T17 Arg:E84 Arg2:E85
T18	Procedure 318 325	surgery
E18	Procedure:T18 Name:T102
T19	Condition 331 336	Tumor
E19	Condition:T19 Name:T103
T20	And 347 350	and
E20	And:T20 Arg:E87 Arg2:E21
T21	Modifier 351 363	localization
E21	Modifier:T21 Modifies:T103
T22	Procedure 377 394	radiochemotherapy
E22	Procedure:T22 Name:T139
T24	Modifier 421 442	Simultaneous standard
E24	Modifier:T24 Modifies:T105
T25	Procedure 443 455	chemotherapy
E25	Procedure:T25 Name:T105
T26	Drug 461 470	cisplatin
E26	Drug:T26 Name:T106
T27	Negation 483 485	no
E27	Negation:T27 Negates:E28
T30	Procedure 511 517	Dental
E30	Procedure:T30 Name:T108
T31	And 530 533	and
E31	And:T31 Arg:E89 Arg2:E29
T32	Temporal-Connection 545 551	before
E32	Temporal-Connection:T32 Arg:E30 Arg2:E33
A1	Temporal-Connection-Type-Value E32 before
T33	Eq-Comparison 552 557	start
E33	Eq-Comparison:T33 Temporal-Recency:T107
T34	Procedure 561 568	therapy
E34	Procedure:T34 Name:T109 Temporality:E33
T35	And 584 588	with
E35	And:T35 Arg:T110 Arg2:E36
T36	Condition 589 611	childbearing potential
E36	Condition:T36 Name:T111
T37	Or 612 615	and
E37	Or:T37 Arg:E36 Arg2:T112
T38	Procedure 650 663	contraception
E38	Procedure:T38 Name:T113 Polarity:T140
T39	Temporal-Connection 812 818	before
E39	Temporal-Connection:T39 Arg:E40
A2	Temporal-Connection-Type-Value E39 before
T40	Study 836 841	trial
E40	Study:T40 
T42	Modifier 935 942	distant
E42	Modifier:T42 Modifies:T114
T43	Condition 943 953	metastases
E43	Condition:T43 Name:T114 Temporality:E41
T44	Condition 955 959	UICC
E44	Condition:T44 Name:T115 Stage:E92
T45	Eq-Comparison 976 984	Previous
E45	Eq-Comparison:T45 Temporal-Period:T116
T46	Procedure 985 997	radiotherapy
E46	Procedure:T46 Name:T117 Temporality:E45
T47	Modifier 1005 1009	head
E47	Modifier:T47 Modifies:T117
T48	Or 1010 1013	and
E48	Or:T48 Arg:E47 Arg2:E49
T49	Modifier 1014 1018	neck
E49	Modifier:T49 Modifies:T117
T52	Condition 1038 1048	malignancy
E52	Condition:T52 Name:T118 Minimum-Count:E50
T53	Assertion 1057 1066	likely to
E53	Assertion:T53 Asserted:E54
A3	Assertion-Type-Value E53 hypothetical
T54	Procedure 1075 1084	treatment
E54	Procedure:T54 
T55	Temporal-Connection 1085 1091	during
E55	Temporal-Connection:T55 Arg:E54 Arg2:E56
A4	Temporal-Connection-Type-Value E55 during
T56	Study 1096 1114	trial intervention
E56	Study:T56 
T58	Or 1115 1117	or
E58	Or:T58 Arg:E56 Arg2:E57
T59	Risk 1196 1200	risk
E59	Risk:T59 Risk-For:E62 Severity:T120
T60	Modifier 1204 1214	recurrence
E60	Modifier:T60 Modifies:T121
T61	Or 1215 1217	or
E61	Or:T61 Arg:E60 Arg2:E62
T62	Condition 1218 1228	metastases
E62	Condition:T62 Name:T121
T63	Encounter 1240 1249	follow-up
E63	Encounter:T63 
T64	Condition 1270 1277	disease
E64	Condition:T64 Name:T124 Severity:T123
T65	Or 1278 1280	or
E65	Or:T65 Arg:E64 Arg2:E66
T66	Condition 1281 1298	medical condition
E66	Condition:T66 
T67	And 1299 1303	with
E67	And:T67 Arg:E66 Arg2:E68
T68	Observation 1304 1319	life expectancy
E68	Observation:T68 Name:T125 Eq-Comparison:E69
T69	Eq-Comparison 1323 1341	less than one year
E69	Eq-Comparison:T69 Operator:T126 Value:T127 Temporal-Unit:T128
T70	Study 1374 1394	interventional trial
E70	Study:T70 Study-Of:E71
T71	Procedure 1405 1414	treatment
E71	Procedure:T71 
T74	Procedure 1454 1471	radiochemotherapy
E74	Procedure:T74 Name:T130
T75	Condition 1477 1485	Pregnant
E75	Condition:T75 Name:T131
T76	Or 1486 1488	or
E76	Or:T76 Arg:E75 Arg2:E77
T77	Condition 1489 1498	lactating
E77	Condition:T77 Name:T132
T78	Negation 1519 1522	not
E78	Negation:T78 Negates:E79
T79	Assertion 1523 1530	able to
E79	Assertion:T79 Asserted:E80
A6	Assertion-Type-Value E79 hypothetical
T80	Risk 1571 1583	consequences
E80	Risk:T80 
T81	Study 1591 1596	trial
E81	Study:T81 
T82	Condition 1602 1627	Nasopharyngeal Carcinomas
E82	Condition:T82 Name:T135
T83	Eq-Operator 30 40	older than
A7	Eq-Operator-Value T83 GT
T84	Eq-Value 41 43	18
T85	Eq-Temporal-Unit 44 49	years
A8	Eq-Temporal-Unit-Value T85 year
T86	Observation-Name 60 64	ECOG
T87	Eq-Value 85 86	0
T88	Eq-Operator 86 87	-
A9	Eq-Operator-Value T88 BETWEEN
T89	Eq-Value 87 88	2
T90	Condition-Name 114 119	HNSCC
T91	Condition-Name 125 128	HPV
T92	Condition-Name 148 151	HPV
T93	Polarity 152 160	positive
A10	Polarity-Value T93 positive
T95	Eq-Unit 173 178	Stage
T96	Eq-Value 179 182	III
T99	Condition-Name 244 249	Tumor
T102	Procedure-Name 318 325	surgery
T103	Condition-Name 331 336	Tumor
T105	Procedure-Name 443 455	chemotherapy
T106	Drug-Name 461 470	cisplatin
T108	Procedure-Name 511 517	Dental
T109	Procedure-Name 561 568	therapy
T110	Life-Stage-And-Gender 578 583	women
A11	Life-Stage-And-Gender-Type T110 female
T111	Condition-Name 589 611	childbearing potential
T112	Life-Stage-And-Gender 616 619	men
A12	Life-Stage-And-Gender-Type T112 male
T113	Procedure-Name 650 663	contraception
T114	Condition-Name 943 953	metastases
T115	Condition-Name 955 959	UICC
T116	Eq-Temporal-Period 976 984	Previous
A13	Eq-Temporal-Period-Value T116 past
T117	Procedure-Name 985 997	radiotherapy
T118	Condition-Name 1038 1048	malignancy
T120	Severity 1183 1195	considerable
A14	Severity-Value T120 severe
T121	Condition-Name 1218 1228	metastases
T123	Severity 1262 1269	Serious
A16	Severity-Value T123 severe
T124	Condition-Name 1270 1277	disease
T125	Observation-Name 1304 1319	life expectancy
T126	Eq-Operator 1323 1332	less than
A17	Eq-Operator-Value T126 LT
T127	Eq-Value 1333 1336	one
T128	Eq-Temporal-Unit 1337 1341	year
A18	Eq-Temporal-Unit-Value T128 year
T129	Condition-Name 1398 1404	cancer
T130	Procedure-Name 1454 1471	radiochemotherapy
T131	Condition-Name 1477 1485	Pregnant
T132	Condition-Name 1489 1498	lactating
T133	Life-Stage-And-Gender 1499 1504	women
A19	Life-Stage-And-Gender-Type T133 female
T135	Condition-Name 1602 1627	Nasopharyngeal Carcinomas
T51	Modifier 161 167	tumors
E51	Modifier:T51 Modifies:T92
T94	Polarity 129 137	negative
A20	Polarity-Value T94 negative
T136	Modifier 138 144	tumors
E83	Modifier:T136 Modifies:T91
T10	Modifier 184 187	IVA
E10	Modifier:T10 Modifies:T97
T97	Condition-Name 195 200	HNSCC
T98	Condition 244 249	Tumor
E84	Condition:T98 Name:T99
T100	Negation 310 317	refused
E85	Negation:T100 Negates:E18
T101	Assertion 310 317	refused
E86	Assertion:T101 Asserted:E85
A21	Assertion-Type-Value E86 hypothetical
T137	Modifier 337 346	extension
E87	Modifier:T137 Modifies:T103
T138	Assertion 364 376	suitable for
E88	Assertion:T138 Asserted:E22
A22	Assertion-Type-Value E88 hypothetical
T139	Procedure-Name 377 394	radiochemotherapy
R1	Treatment-For Arg1:E22 Arg2:E19	
R2	Using Arg1:E25 Arg2:E26	
T23	Assertion 471 481	applicable
E23	Assertion:T23 Asserted:E25
A23	Assertion-Type-Value E23 hypothetical
T28	Contraindication 486 504	contra-indications
E28	Contraindication:T28 Contraindicates:E25
T29	Modifier 535 544	treatment
E29	Modifier:T29 Modifies:T108
T104	Modifier 518 529	examination
E89	Modifier:T104 Modifies:T108
T107	Eq-Temporal-Recency 552 557	start
A24	Eq-Temporal-Recency-Value T107 first-time
T140	Polarity 641 649	adequate
A25	Polarity-Value T140 normal
T141	Condition 623 640	reproductive ages
E90	Condition:T141 Name:T142
T142	Condition-Name 623 640	reproductive ages
T143	And 620 622	in
E91	And:T143 Arg:T112 Arg2:E90
T41	Eq-Comparison 923 931	Presence
E41	Eq-Comparison:T41 Temporal-Period:T144
T144	Eq-Temporal-Period 923 931	Presence
A26	Eq-Temporal-Period-Value T144 present
T145	Eq-Comparison 960 969	stage IVC
E92	Eq-Comparison:T145 Unit:T146 Value:T147
T146	Eq-Unit 960 965	stage
T147	Eq-Value 966 969	IVC
R3	Equivalent-To Arg1:E44 Arg2:E43	
T50	Eq-Comparison 1031 1037	Second
E50	Eq-Comparison:T50 Value:T148
T148	Eq-Value 1031 1037	Second
R4	Treatment-For Arg1:E54 Arg2:E52	
T57	Encounter 1118 1127	follow-up
E57	Encounter:T57 
R5	Caused-By Arg1:E59 Arg2:E52	
T119	Temporal-Connection 1229 1235	within
E93	Temporal-Connection:T119 Arg:E62 Arg2:E63
A15	Temporal-Connection-Type-Value E93 during
T122	Other 1364 1373	competing
E94	Other:T122 Is-Other:E70
T149	Condition 1398 1404	cancer
E95	Condition:T149 Name:T129
R6	Treatment-For Arg1:E71 Arg2:E95	
T72	Contraindication 1437 1449	not suitable
E72	Contraindication:T72 Contraindicates:E74
R7	If-Then Arg1:T133 Arg2:E77	
R8	Caused-By Arg1:E80 Arg2:E81	
